HEADER MEMBRANE PROTEIN 24-MAR-17 5NIH TITLE CRYSTAL STRUCTURE OF THE GLUA2 LIGAND-BINDING DOMAIN (S1S2J) IN TITLE 2 COMPLEX WITH AGONIST LM-12B AT 1.3 A RESOLUTION. COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE RECEPTOR 2; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: GLUR-2,AMPA-SELECTIVE GLUTAMATE RECEPTOR 2,GLUR-B,GLUR-K2, COMPND 5 GLUTAMATE RECEPTOR IONOTROPIC,AMPA 2,GLUA2; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THE PROTEIN CRYSTALLIZED IS THE EXTRACELLULAR LIGAND- COMPND 8 BINDING DOMIAN OF GLUA2. TRANSMEMBRANE REGIONS WERE REPLACED WITH A COMPND 9 GLY-THR LINKER (118-119). SEQUENCE MATCHES DISCONTINUOUSLY WITH THE COMPND 10 REFERENCE DATABASE (413-527, 653-797). RESIDUES 1-2 ARE CLONING COMPND 11 REMNANTS. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: GRIA2, GLUR2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ORIGAMI B; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS IONOTROPIC GLUTAMATE RECEPTOR, AMPA RECEPTOR, LIGAND-BINDING DOMAIN, KEYWDS 2 GLUA2, GLUR2, AGONIST, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.LAULUMAA,K.A.FRYDENVANG,J.S.KASTRUP REVDAT 5 06-NOV-24 5NIH 1 REMARK REVDAT 4 17-JAN-24 5NIH 1 REMARK REVDAT 3 07-MAR-18 5NIH 1 SOURCE REVDAT 2 27-SEP-17 5NIH 1 JRNL REVDAT 1 26-JUL-17 5NIH 0 JRNL AUTH S.MLLERUD,A.PINTO,L.MARCONI,K.FRYDENVANG,T.S.THORSEN, JRNL AUTH 2 S.LAULUMAA,R.VENSKUTONYTE,S.WINTHER,A.M.C.MORAL,L.TAMBORINI, JRNL AUTH 3 P.CONTI,D.S.PICKERING,J.S.KASTRUP JRNL TITL STRUCTURE AND AFFINITY OF TWO BICYCLIC GLUTAMATE ANALOGUES JRNL TITL 2 AT AMPA AND KAINATE RECEPTORS. JRNL REF ACS CHEM NEUROSCI V. 8 2056 2017 JRNL REFN ESSN 1948-7193 JRNL PMID 28691798 JRNL DOI 10.1021/ACSCHEMNEURO.7B00201 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.27 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.310 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 131162 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.128 REMARK 3 R VALUE (WORKING SET) : 0.127 REMARK 3 FREE R VALUE : 0.158 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 6452 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.3008 - 4.0386 0.99 4392 235 0.1744 0.1835 REMARK 3 2 4.0386 - 3.2058 1.00 4285 217 0.1280 0.1532 REMARK 3 3 3.2058 - 2.8006 1.00 4239 218 0.1359 0.1706 REMARK 3 4 2.8006 - 2.5446 1.00 4188 230 0.1262 0.1438 REMARK 3 5 2.5446 - 2.3622 1.00 4194 220 0.1206 0.1581 REMARK 3 6 2.3622 - 2.2229 1.00 4185 226 0.1116 0.1467 REMARK 3 7 2.2229 - 2.1116 1.00 4182 205 0.1103 0.1387 REMARK 3 8 2.1116 - 2.0197 1.00 4147 223 0.1096 0.1438 REMARK 3 9 2.0197 - 1.9419 1.00 4210 197 0.1126 0.1426 REMARK 3 10 1.9419 - 1.8749 1.00 4127 227 0.1077 0.1534 REMARK 3 11 1.8749 - 1.8163 1.00 4132 239 0.1079 0.1301 REMARK 3 12 1.8163 - 1.7644 1.00 4141 221 0.1084 0.1270 REMARK 3 13 1.7644 - 1.7179 1.00 4139 206 0.1100 0.1590 REMARK 3 14 1.7179 - 1.6760 1.00 4165 205 0.1053 0.1403 REMARK 3 15 1.6760 - 1.6379 1.00 4099 241 0.1068 0.1591 REMARK 3 16 1.6379 - 1.6030 1.00 4163 193 0.1093 0.1414 REMARK 3 17 1.6030 - 1.5710 1.00 4107 218 0.1107 0.1571 REMARK 3 18 1.5710 - 1.5413 1.00 4131 223 0.1145 0.1470 REMARK 3 19 1.5413 - 1.5138 1.00 4137 205 0.1131 0.1637 REMARK 3 20 1.5138 - 1.4881 1.00 4133 204 0.1153 0.1451 REMARK 3 21 1.4881 - 1.4641 1.00 4147 199 0.1238 0.1696 REMARK 3 22 1.4641 - 1.4416 1.00 4089 241 0.1298 0.1944 REMARK 3 23 1.4416 - 1.4204 1.00 4079 196 0.1358 0.1787 REMARK 3 24 1.4204 - 1.4004 1.00 4171 207 0.1371 0.1849 REMARK 3 25 1.4004 - 1.3815 1.00 4119 220 0.1423 0.1820 REMARK 3 26 1.3815 - 1.3635 1.00 4107 198 0.1424 0.1823 REMARK 3 27 1.3635 - 1.3465 1.00 4130 224 0.1442 0.1770 REMARK 3 28 1.3465 - 1.3302 1.00 4099 211 0.1497 0.1872 REMARK 3 29 1.3302 - 1.3148 1.00 4099 223 0.1585 0.2124 REMARK 3 30 1.3148 - 1.3000 1.00 4174 180 0.1672 0.2031 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.090 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.850 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.35 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4571 REMARK 3 ANGLE : 1.026 6228 REMARK 3 CHIRALITY : 0.079 685 REMARK 3 PLANARITY : 0.006 786 REMARK 3 DIHEDRAL : 19.621 1805 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NIH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1200004058. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8729 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.22 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 131334 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 96.535 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06300 REMARK 200 FOR THE DATA SET : 14.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : 0.46500 REMARK 200 R SYM FOR SHELL (I) : 0.46500 REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1M5B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24.4% PEG4000, 0.3 M AMMONIUM SULFATE, REMARK 280 0.1 M PHOSPHATE-CITRATE BUFFER, PH 4.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 279K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.28850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.26750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.97700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.26750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.28850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.97700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 1 REMARK 465 ALA B 2 REMARK 465 ASN B 3 REMARK 465 GLY B 264 REMARK 465 SER A 263 REMARK 465 GLY A 264 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 735 O HOH B 740 1.90 REMARK 500 O HOH A 679 O HOH A 700 2.00 REMARK 500 O HOH B 434 O HOH B 532 2.12 REMARK 500 O HOH A 455 O HOH A 729 2.13 REMARK 500 O HOH B 434 O HOH B 740 2.13 REMARK 500 O HOH A 646 O HOH A 701 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 714 O HOH A 560 2375 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 255 -62.00 -105.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 800 DISTANCE = 5.96 ANGSTROMS REMARK 525 HOH B 801 DISTANCE = 6.29 ANGSTROMS REMARK 525 HOH B 802 DISTANCE = 6.76 ANGSTROMS REMARK 525 HOH B 803 DISTANCE = 7.00 ANGSTROMS REMARK 525 HOH A 773 DISTANCE = 6.30 ANGSTROMS REMARK 525 HOH A 774 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH A 775 DISTANCE = 6.82 ANGSTROMS REMARK 525 HOH A 776 DISTANCE = 7.65 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8VE B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8VE A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 309 DBREF 5NIH B 3 117 UNP P19491 GRIA2_RAT 413 527 DBREF 5NIH B 120 264 UNP P19491 GRIA2_RAT 653 797 DBREF 5NIH A 3 117 UNP P19491 GRIA2_RAT 413 527 DBREF 5NIH A 120 264 UNP P19491 GRIA2_RAT 653 797 SEQADV 5NIH GLY B 1 UNP P19491 CLONING ARTIFACT SEQADV 5NIH ALA B 2 UNP P19491 CLONING ARTIFACT SEQADV 5NIH GLY B 118 UNP P19491 LINKER SEQADV 5NIH THR B 119 UNP P19491 LINKER SEQADV 5NIH GLY A 1 UNP P19491 CLONING ARTIFACT SEQADV 5NIH ALA A 2 UNP P19491 CLONING ARTIFACT SEQADV 5NIH GLY A 118 UNP P19491 LINKER SEQADV 5NIH THR A 119 UNP P19491 LINKER SEQRES 1 B 264 GLY ALA ASN LYS THR VAL VAL VAL THR THR ILE LEU GLU SEQRES 2 B 264 SER PRO TYR VAL MET MET LYS LYS ASN HIS GLU MET LEU SEQRES 3 B 264 GLU GLY ASN GLU ARG TYR GLU GLY TYR CYS VAL ASP LEU SEQRES 4 B 264 ALA ALA GLU ILE ALA LYS HIS CYS GLY PHE LYS TYR LYS SEQRES 5 B 264 LEU THR ILE VAL GLY ASP GLY LYS TYR GLY ALA ARG ASP SEQRES 6 B 264 ALA ASP THR LYS ILE TRP ASN GLY MET VAL GLY GLU LEU SEQRES 7 B 264 VAL TYR GLY LYS ALA ASP ILE ALA ILE ALA PRO LEU THR SEQRES 8 B 264 ILE THR LEU VAL ARG GLU GLU VAL ILE ASP PHE SER LYS SEQRES 9 B 264 PRO PHE MET SER LEU GLY ILE SER ILE MET ILE LYS LYS SEQRES 10 B 264 GLY THR PRO ILE GLU SER ALA GLU ASP LEU SER LYS GLN SEQRES 11 B 264 THR GLU ILE ALA TYR GLY THR LEU ASP SER GLY SER THR SEQRES 12 B 264 LYS GLU PHE PHE ARG ARG SER LYS ILE ALA VAL PHE ASP SEQRES 13 B 264 LYS MET TRP THR TYR MET ARG SER ALA GLU PRO SER VAL SEQRES 14 B 264 PHE VAL ARG THR THR ALA GLU GLY VAL ALA ARG VAL ARG SEQRES 15 B 264 LYS SER LYS GLY LYS TYR ALA TYR LEU LEU GLU SER THR SEQRES 16 B 264 MET ASN GLU TYR ILE GLU GLN ARG LYS PRO CYS ASP THR SEQRES 17 B 264 MET LYS VAL GLY GLY ASN LEU ASP SER LYS GLY TYR GLY SEQRES 18 B 264 ILE ALA THR PRO LYS GLY SER SER LEU GLY ASN ALA VAL SEQRES 19 B 264 ASN LEU ALA VAL LEU LYS LEU ASN GLU GLN GLY LEU LEU SEQRES 20 B 264 ASP LYS LEU LYS ASN LYS TRP TRP TYR ASP LYS GLY GLU SEQRES 21 B 264 CYS GLY SER GLY SEQRES 1 A 264 GLY ALA ASN LYS THR VAL VAL VAL THR THR ILE LEU GLU SEQRES 2 A 264 SER PRO TYR VAL MET MET LYS LYS ASN HIS GLU MET LEU SEQRES 3 A 264 GLU GLY ASN GLU ARG TYR GLU GLY TYR CYS VAL ASP LEU SEQRES 4 A 264 ALA ALA GLU ILE ALA LYS HIS CYS GLY PHE LYS TYR LYS SEQRES 5 A 264 LEU THR ILE VAL GLY ASP GLY LYS TYR GLY ALA ARG ASP SEQRES 6 A 264 ALA ASP THR LYS ILE TRP ASN GLY MET VAL GLY GLU LEU SEQRES 7 A 264 VAL TYR GLY LYS ALA ASP ILE ALA ILE ALA PRO LEU THR SEQRES 8 A 264 ILE THR LEU VAL ARG GLU GLU VAL ILE ASP PHE SER LYS SEQRES 9 A 264 PRO PHE MET SER LEU GLY ILE SER ILE MET ILE LYS LYS SEQRES 10 A 264 GLY THR PRO ILE GLU SER ALA GLU ASP LEU SER LYS GLN SEQRES 11 A 264 THR GLU ILE ALA TYR GLY THR LEU ASP SER GLY SER THR SEQRES 12 A 264 LYS GLU PHE PHE ARG ARG SER LYS ILE ALA VAL PHE ASP SEQRES 13 A 264 LYS MET TRP THR TYR MET ARG SER ALA GLU PRO SER VAL SEQRES 14 A 264 PHE VAL ARG THR THR ALA GLU GLY VAL ALA ARG VAL ARG SEQRES 15 A 264 LYS SER LYS GLY LYS TYR ALA TYR LEU LEU GLU SER THR SEQRES 16 A 264 MET ASN GLU TYR ILE GLU GLN ARG LYS PRO CYS ASP THR SEQRES 17 A 264 MET LYS VAL GLY GLY ASN LEU ASP SER LYS GLY TYR GLY SEQRES 18 A 264 ILE ALA THR PRO LYS GLY SER SER LEU GLY ASN ALA VAL SEQRES 19 A 264 ASN LEU ALA VAL LEU LYS LEU ASN GLU GLN GLY LEU LEU SEQRES 20 A 264 ASP LYS LEU LYS ASN LYS TRP TRP TYR ASP LYS GLY GLU SEQRES 21 A 264 CYS GLY SER GLY HET SO4 B 301 5 HET SO4 B 302 5 HET 8VE B 303 15 HET GOL B 304 6 HET CL B 305 1 HET SO4 A 301 5 HET SO4 A 302 5 HET SO4 A 303 5 HET 8VE A 304 15 HET GOL A 305 6 HET GOL A 306 6 HET GOL A 307 6 HET ACT A 308 4 HET CL A 309 1 HETNAM SO4 SULFATE ION HETNAM 8VE (3~{A}~{R},4~{S},6~{A}~{R})-1-METHYL-4,5,6,6~{A}- HETNAM 2 8VE TETRAHYDRO-3~{A}~{H}-PYRROLO[3,4-C]PYRAZOLE-3,4- HETNAM 3 8VE DICARBOXYLIC ACID HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETNAM ACT ACETATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 SO4 5(O4 S 2-) FORMUL 5 8VE 2(C8 H11 N3 O4) FORMUL 6 GOL 4(C3 H8 O3) FORMUL 7 CL 2(CL 1-) FORMUL 15 ACT C2 H3 O2 1- FORMUL 17 HOH *779(H2 O) HELIX 1 AA1 ASN B 22 LEU B 26 5 5 HELIX 2 AA2 GLU B 27 GLU B 30 5 4 HELIX 3 AA3 GLY B 34 GLY B 48 1 15 HELIX 4 AA4 ASN B 72 TYR B 80 1 9 HELIX 5 AA5 THR B 93 GLU B 98 1 6 HELIX 6 AA6 SER B 123 LYS B 129 1 7 HELIX 7 AA7 GLY B 141 SER B 150 1 10 HELIX 8 AA8 ILE B 152 ALA B 165 1 14 HELIX 9 AA9 THR B 173 SER B 184 1 12 HELIX 10 AB1 SER B 194 GLN B 202 1 9 HELIX 11 AB2 SER B 229 GLN B 244 1 16 HELIX 12 AB3 GLY B 245 TYR B 256 1 12 HELIX 13 AB4 ASN A 22 LEU A 26 5 5 HELIX 14 AB5 GLU A 27 GLU A 30 5 4 HELIX 15 AB6 GLY A 34 GLY A 48 1 15 HELIX 16 AB7 ASN A 72 TYR A 80 1 9 HELIX 17 AB8 THR A 93 GLU A 98 1 6 HELIX 18 AB9 SER A 123 LYS A 129 1 7 HELIX 19 AC1 GLY A 141 SER A 150 1 10 HELIX 20 AC2 ILE A 152 ALA A 165 1 14 HELIX 21 AC3 THR A 173 SER A 184 1 12 HELIX 22 AC4 SER A 194 GLN A 202 1 9 HELIX 23 AC5 SER A 229 GLN A 244 1 16 HELIX 24 AC6 GLY A 245 TRP A 255 1 11 SHEET 1 AA1 3 TYR B 51 ILE B 55 0 SHEET 2 AA1 3 VAL B 6 THR B 10 1 N VAL B 8 O LYS B 52 SHEET 3 AA1 3 ILE B 85 ALA B 86 1 O ILE B 85 N THR B 9 SHEET 1 AA2 2 MET B 18 MET B 19 0 SHEET 2 AA2 2 TYR B 32 GLU B 33 -1 O GLU B 33 N MET B 18 SHEET 1 AA3 2 ILE B 100 PHE B 102 0 SHEET 2 AA3 2 ALA B 223 PRO B 225 -1 O THR B 224 N ASP B 101 SHEET 1 AA4 2 MET B 107 LEU B 109 0 SHEET 2 AA4 2 LYS B 218 TYR B 220 -1 O LYS B 218 N LEU B 109 SHEET 1 AA5 4 ALA B 134 THR B 137 0 SHEET 2 AA5 4 TYR B 188 GLU B 193 1 O LEU B 191 N GLY B 136 SHEET 3 AA5 4 ILE B 111 LYS B 116 -1 N MET B 114 O TYR B 190 SHEET 4 AA5 4 THR B 208 VAL B 211 -1 O MET B 209 N ILE B 115 SHEET 1 AA6 3 TYR A 51 ILE A 55 0 SHEET 2 AA6 3 VAL A 6 THR A 10 1 N VAL A 8 O LYS A 52 SHEET 3 AA6 3 ILE A 85 ALA A 86 1 O ILE A 85 N THR A 9 SHEET 1 AA7 2 MET A 18 MET A 19 0 SHEET 2 AA7 2 TYR A 32 GLU A 33 -1 O GLU A 33 N MET A 18 SHEET 1 AA8 2 ILE A 100 PHE A 102 0 SHEET 2 AA8 2 ALA A 223 PRO A 225 -1 O THR A 224 N ASP A 101 SHEET 1 AA9 2 MET A 107 LEU A 109 0 SHEET 2 AA9 2 LYS A 218 TYR A 220 -1 O LYS A 218 N LEU A 109 SHEET 1 AB1 4 ALA A 134 THR A 137 0 SHEET 2 AB1 4 TYR A 188 GLU A 193 1 O LEU A 191 N GLY A 136 SHEET 3 AB1 4 ILE A 111 LYS A 116 -1 N MET A 114 O TYR A 190 SHEET 4 AB1 4 THR A 208 VAL A 211 -1 O MET A 209 N ILE A 115 SSBOND 1 CYS B 206 CYS B 261 1555 1555 2.04 SSBOND 2 CYS A 206 CYS A 261 1555 1555 2.04 CISPEP 1 SER B 14 PRO B 15 0 -3.39 CISPEP 2 GLU B 166 PRO B 167 0 -6.20 CISPEP 3 LYS B 204 PRO B 205 0 6.87 CISPEP 4 SER A 14 PRO A 15 0 -1.43 CISPEP 5 GLU A 166 PRO A 167 0 -6.10 CISPEP 6 LYS A 204 PRO A 205 0 6.04 SITE 1 AC1 10 HIS A 46 LYS A 240 HOH A 407 HOH A 708 SITE 2 AC1 10 HIS B 23 ARG B 31 HOH B 421 HOH B 456 SITE 3 AC1 10 HOH B 466 HOH B 570 SITE 1 AC2 8 ASN B 29 GLU B 30 ARG B 149 HOH B 403 SITE 2 AC2 8 HOH B 558 HOH B 569 HOH B 645 HOH B 710 SITE 1 AC3 17 GLU B 13 TYR B 61 PRO B 89 THR B 91 SITE 2 AC3 17 ARG B 96 LEU B 138 GLY B 141 SER B 142 SITE 3 AC3 17 THR B 143 THR B 174 GLU B 193 MET B 196 SITE 4 AC3 17 HOH B 484 HOH B 519 HOH B 578 HOH B 605 SITE 5 AC3 17 HOH B 606 SITE 1 AC4 5 HOH A 403 HOH A 708 ARG B 31 LYS B 151 SITE 2 AC4 5 HOH B 644 SITE 1 AC5 2 ALA B 153 HOH B 431 SITE 1 AC6 4 ASN A 22 ARG A 64 HOH A 587 HOH A 627 SITE 1 AC7 8 HIS A 23 ARG A 31 HOH A 419 HOH A 449 SITE 2 AC7 8 HOH A 470 HOH A 480 HIS B 46 LYS B 240 SITE 1 AC8 8 GLU A 97 ASP A 101 PHE A 102 HOH A 411 SITE 2 AC8 8 HOH A 416 HOH A 463 HOH A 582 LYS B 104 SITE 1 AC9 17 GLU A 13 TYR A 61 PRO A 89 THR A 91 SITE 2 AC9 17 ARG A 96 LEU A 138 GLY A 141 SER A 142 SITE 3 AC9 17 THR A 143 THR A 174 GLU A 193 MET A 196 SITE 4 AC9 17 HOH A 445 HOH A 447 HOH A 530 HOH A 559 SITE 5 AC9 17 HOH A 637 SITE 1 AD1 6 LYS A 117 GLU A 201 GLN A 202 CYS A 261 SITE 2 AD1 6 HOH A 454 HOH B 753 SITE 1 AD2 8 LEU A 12 GLY A 59 HOH A 410 HOH A 432 SITE 2 AD2 8 HOH A 437 HOH A 452 HOH A 508 HOH A 598 SITE 1 AD3 7 GLU A 27 ASN A 29 GLU A 30 ARG A 148 SITE 2 AD3 7 ARG A 149 HOH A 574 HOH A 677 SITE 1 AD4 4 ARG A 148 TRP A 159 ARG A 163 HOH A 626 SITE 1 AD5 2 ALA A 153 HOH A 605 CRYST1 62.577 87.954 96.535 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015980 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011370 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010359 0.00000